Home > Publications database > Emerge of colorectal cancer in Lynch syndrome despite colonoscopy surveillance: A challenge of hide and seek. > print |
001 | 289122 | ||
005 | 20250825122416.0 | ||
024 | 7 | _ | |a 10.1016/j.critrevonc.2024.104331 |2 doi |
024 | 7 | _ | |a pmid:38521284 |2 pmid |
024 | 7 | _ | |a 0737-9587 |2 ISSN |
024 | 7 | _ | |a 1040-8428 |2 ISSN |
024 | 7 | _ | |a 1879-0461 |2 ISSN |
024 | 7 | _ | |a altmetric:161149955 |2 altmetric |
037 | _ | _ | |a DKFZ-2024-00589 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Helderman, Noah C |b 0 |
245 | _ | _ | |a Emerge of colorectal cancer in Lynch syndrome despite colonoscopy surveillance: A challenge of hide and seek. |
260 | _ | _ | |a Amsterdam [u.a.] |c 2024 |b Elsevier Science |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1712309409_10719 |2 PUB:(DE-HGF) |x Review Article |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a Even with colonoscopy surveillance, Lynch syndromes (LS) carriers still develop colorectal cancer (CRC). The cumulative incidence of CRCs under colonoscopy surveillance varies depending on the affected mismatch repair (MMR) gene. However, the precise mechanisms driving these epidemiological patterns remain incompletely understood. In recent years, several potential mechanisms explaining the occurrence of CRCs during colonoscopy surveillance have been proposed in individuals with and without LS. These encompass biological factors like concealed/accelerated carcinogenesis through a bypassed adenoma stage and accelerated progression from adenomas. Alongside these, various colonoscopy-related factors may contribute to formation of CRCs under colonoscopy surveillance, like missed yet detectable (pre)cancerous lesions, detected yet incompletely removed (pre)cancerous lesions, and colonoscopy-induced carcinogenesis due to tumor cell reimplantation. In this comprehensive literature update, we reviewed these potential factors and evaluated their relevance to each MMR group in an attempt to raise further awareness and stimulate research regarding this conflicting phenomenon. |
536 | _ | _ | |a 314 - Immunologie und Krebs (POF4-314) |0 G:(DE-HGF)POF4-314 |c POF4-314 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
650 | _ | 7 | |a Colonoscopy surveillance |2 Other |
650 | _ | 7 | |a Colorectal cancer |2 Other |
650 | _ | 7 | |a Incident colorectal cancer |2 Other |
650 | _ | 7 | |a Lynch syndrome |2 Other |
650 | _ | 7 | |a Mismatch repair |2 Other |
650 | _ | 7 | |a Post-colonoscopy colorectal cancer |2 Other |
700 | 1 | _ | |a van Leerdam, Monique E |b 1 |
700 | 1 | _ | |a Kloor, Matthias |0 P:(DE-He78)028ee60cca729028708496826f077b58 |b 2 |u dkfz |
700 | 1 | _ | |a Ahadova, Aysel |0 P:(DE-He78)07eef6d38a91f4642c810745c5bf5000 |b 3 |u dkfz |
700 | 1 | _ | |a Nielsen, Maartje |b 4 |
773 | _ | _ | |a 10.1016/j.critrevonc.2024.104331 |g Vol. 197, p. 104331 - |0 PERI:(DE-600)2025731-4 |p 104331 |t Critical reviews in oncology, hematology |v 197 |y 2024 |x 0737-9587 |
856 | 4 | _ | |u https://inrepo02.dkfz.de/record/289122/files/1-s2.0-S104084282400074X-main.pdf |
856 | 4 | _ | |u https://inrepo02.dkfz.de/record/289122/files/1-s2.0-S104084282400074X-main.pdf?subformat=pdfa |x pdfa |
909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:289122 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)028ee60cca729028708496826f077b58 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)07eef6d38a91f4642c810745c5bf5000 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-314 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Immunologie und Krebs |x 0 |
914 | 1 | _ | |y 2024 |
915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2023-10-24 |w ger |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CRIT REV ONCOL HEMAT : 2022 |d 2023-10-24 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-24 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-24 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-10-24 |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-10-24 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-24 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-10-24 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-10-24 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-24 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1120 |2 StatID |b BIOSIS Reviews Reports And Meetings |d 2023-10-24 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-10-24 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2023-10-24 |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b CRIT REV ONCOL HEMAT : 2022 |d 2023-10-24 |
920 | 1 | _ | |0 I:(DE-He78)F210-20160331 |k F210 |l KKE Angewandte Tumorbiologie |x 0 |
920 | 1 | _ | |0 I:(DE-He78)D470-20160331 |k D470 |l KKE Angewandte Tumorbiologie |x 1 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)F210-20160331 |
980 | _ | _ | |a I:(DE-He78)D470-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|